Impel Pharmaceuticals Inc.

Impel Pharmaceuticals Announces Filing of Voluntary Chapter 11 Cases and Signing of "Stalking Horse" Agreement to Facilitate Sale

Why Is Impel Pharmaceuticals (IMPL) Stock Up 32% Today?

Why Is Impel Pharmaceuticals (IMPL) Stock Down 35% Today?

Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society

Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023

Impel Pharmaceuticals Inc. (IMPL) Q4 2022 Earnings Call Transcript

Impel Pharmaceuticals Inc. (IMPL) Reports Q4 Loss, Tops Revenue Estimates

Impel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023

Impel Pharmaceuticals to Participate in Upcoming Investor Conferences in March

Impel Pharmaceuticals Inc. (IMPL) Q3 2022 Earnings Call Transcript

Impel Pharmaceuticals, Inc. (IMPL) CEO Adrian Adams on Q2 2022 Results - Earnings Call Transcript

Impel Pharmaceuticals Inc. (IMPL) Reports Q2 Loss, Tops Revenue Estimates

Impel Pharmaceuticals: Under The Radar Despite Upside Potential

Impel Pharmaceuticals to Present Trudhesa® Data at the 64th Annual Meeting of the American Headache Society

Impel Pharmaceuticals To Present At The JMP Securities Life Sciences Conference

Impel NeuroPharma, Inc. (IMPL) CEO Adrian Adams on Q1 2022 Results - Earnings Call Transcript

Impel Pharmaceuticals Inc. (IMPL) Reports Q1 Loss, Tops Revenue Estimates

Impel Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference

Impel Pharmaceuticals to Report First Quarter 2022 Financial Results on Monday, May 16, 2022

Impel NeuroPharma To Present At The 21st Annual Needham Healthcare Conference